Thirty-one females with incontinentia pigmenti (IP), 42 controls, and 11 females from four families segregating for X linked lymphoproliferative disease (XLP) were studied for evidence of skewed X inactivation by analysis of methylation at sites in the HPRT, PGK, and M27a8 (DXS255) regions of the X chromosome. Extensive skewing of X inactivation was present in blood from 4/ 42 (9-5%) control females and 11/31 (35%) of those with IP. This frequency of skewed inactivation was seen in both familial and sporadic cases of IP. Analysis of inactivation in mother/daughter pairs, both affected and control subjects, showed no familial consistency of pattern, arguing against specific mutations being associated with particular patterns of inactivation. In the only informative family where both mother and daughter were affected by IP and showed skewed inactivation, the IP mutation was on the active X chromosome. This argues against cell selection during early embryogenesis being the explanation for the skewed inactivation observed.
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These data confirm that skewed inactivation of one X is observed in lymphocytes from a significant minority of normal females, and is seen with raised frequency in IP heterozygotes. It is not, however, a universally observed phenomenon, and the relationship of X inactivity to the IP mutation appears to be complex.
In the case of XLP, though skewed X inactivation patterns are seen in most disease carriers, the frequency with which this phenomenon occurs in normal females renders it an unreliable diagnostic marker for XLP carriers.
(J Med Genet 1992;29:608-14)
The phenomenon of random inactivation of one X chromosome in all somatic tissues of a female was first reported nearly 30 years ago.'
Since then, certain exceptions to the random nature of this inactivation have become apparent. Of particular interest are those X linked, male lethal diseases in which carrier females show skewed pattems of X inactivation in certain tissues. It has been suggested that in these cases cells carrying the lethal allele on their active X chromosome might be selected against.2 The skewed patterns of X inactivation which would result from this type of selection might either be observed in a variety of tissues in the female body, or only within those cell lineages in which the normal counterpart of the lethal allele is functionally important. The precise pattern of skewed X inactivation might also reflect the role of a particular gene earlier in development. Further, the pool size in the stem cell population at the time of selection for X activity is likely to be of significance. X linked disorders in which skewed inactivation patterns have been observed in specific cell lineages in carrier females include several of the recessive X linked immunodeficiency diseases. We have also analysed a large cohort of control females who were not known to be carrying any X linked disease, and 11 females from four families segregating for X linked lymphoproliferative disease (XLP, LYP, IMD5). XLP is a rare, recessive disorder that is characterised by the inability of affected subjects to mount a normal immune response to EpsteinBarr virus (EBV)."1 Affected subjects and presumed obligate carrier females usually show abnormal serum antibody responses to EB viral antigens. EBV infection in XLP patients generally causes an initial infectious mononucleosis that progresses rapidly into malignant, polyclonal lymphoproliferative disease.
Recently
The method we have used to establish patterns of X inactivation is the analysis of methylation patterns at specific chromosomal sequences.'4 It is known that at the DNA level the phenomenon of X inactivation can be observed through differential methylation at particular CpG sites. Polymorphisms in the housekeeping genes hypoxanthine phosphoribosyl transferase (HPRT)'5 and phosphoglycerate kinase (PGK),'6 or the hypervariable locus DXS255 detected by the probe M2713,'7-'9 have been used to distinguish active and inactive X chromosomes. The methylation state of the two polymorphic DNA fragments is then investigated using methylation sensitive enzymes that will not cleave methylated DNA.
Materials and methods
Twenty-three familial cases and eight sporadic cases of IP were examined. The family structures are shown in fig 1. All sporadic cases were IP females born to apparently unaffected mothers and with no family history of the disease. Family 1 is resident in the South-East Thames region, families 2 and 3 in South Australia, families 4 to 9 in Hungary, family 10 in Oxford, and family 11 (not shown) in the East Midland region (see acknowledgements). All sporadic cases are Hungarian.
The control females included 28 cystic fibrosis (CF) carriers, nine carriers of known other (non-X linked) diseases including Huntington's chorea (5), Tay-Sachs disease (2), DIDMOAD (diabetes insipidus, diabetes mellitus, and optic atrophy) (1), and ataxia cerebellum (1), and five females not known to be carriers of any genetic disease.
Eleven females from four families segregating for XLP were examined (fig 2) usirig peripheral blood cells (families 1 and 2) or EBV transformed lymphoblastoid cell lines (families 3 and 4 from whom peripheral blood samples were not available). EBV transformed lymphoblastoid cell lines are polyclonal and have been shown not to bias X inactivation patterns,2021 though Migeon et a122 have suggested this polyclonality may be distorted after prolonged periods in culture. Three of these families (fig 2, Nos 2, 3, and 4) have been reported previously.2326 In family 4, serological responses to EBV are abnormal in the female marked C (carrier) and normal in those marked NC (non-carrier). In the other families no immunological data are available to establish carrier status, so the mother and maternal grandmother of one or more affected boys are presumed to be carriers. It is of course possible that a new mutation has arisen either in the XLP patient himself or in his mother, rather than having been inherited from his maternal grandmother.
DNA was extracted from peripheral blood lymphocytes by standard methods. A fibroblast culture was set up from a skin biopsy from one IP patient by standard methods. Epithelial cells were grown from the same skin biopsies by a modification of the technique of Harris and Coleman. 27 The HPRT and M27,B probes detect polymorphisms including a CCGG restriction enzyme site which is methylated on the active X chromosome and therefore resistant to cleavage by HpaII (but not MspI). The PGK probe detects a polymorphism involving a HpaII/MspI site which is methylated on the inactive X chromosome.
Details of the HPRT and PGK polymorphisms are described elsewhere. 1416 (2-3 kb EcoRI insert)30 probes were excised and gel purified on low gelling temperature agarose (BRL) gels and then 32p labelled by standard methods to a specific activity of 1-5 x 101 cpm/ pg. The HPRT probe (100 ng) was pre-reassociated with human placental DNA (300 pg) in 5 x SSC for 30 minutes at 65°C. Filters were washed to a final stringency of 0-2% SSC, 0 1% SDS at 65°C, and then exposed to Kodak XAR5 film.
A total of 31 females with familial (23) or sporadic (eight) IP and 42 non-IP females have been analysed with respect to their patterns of X inactivation. Among the IP patients, 14 were informative at the PGK locus, four at the HPRT locus, and 13 who were uninformative at both these loci were tested at the M273 locus. The 42 non-IP females were all chosen to be informative at the PGK locus. The data are summarised in tables 1 to 3. (table 2B) . However, when measured in terms of the total familial or sporadic population, 39% (9/23) of familial IP females and 25% (2/8) of sporadic IPs are extremely skewed.
In familial IP the X inactivation patterns of mother/daughter pairs has been investigated to see whether the IP lesion is causing consistent patterns from one generation to the next (table  4) . Thirteen mother and daughter pairs have been analysed (fig 1) . Of these, seven show identical patterns of X inactivation (four symmetrical and three skewed) while six do not. In the latter cases the mother shows symmetrical inactivation and the daughter skewed inactivation in four pairs (two mothers each with two daughters, though in one case these are by two different fathers) while two mothers show skewed patterns but have daughters with symmetrical patterns. In one of the three pairs where both mother and daughter show skewed X inactivation, it has been possible to establish whether the paternal or maternal X has been preferentially inactivated in the daughter. In this case the IP lesion is on the active X chromosome.
In the only IP female from whom a skin sample was obtained (fig 1, family 1 It is possible that the use of the probe M271 in the IP population may be biasing observations of X inactivation patterns. Eight out of 11 IP females with extremely skewed X inactivation patterns were assessed with M27f. When the IP and control populations are compared on the basis of PGK data alone, the percentage of females showing extremely skewed X inactivation is 4/42 (9 5%) in normal and 3/14 (21 %) in IP females. X inactivation patterns in four control females have been analysed with both PGK and M271 (A Coffey, unpublished observations). Three of these gave a concordant pattern at the two loci but one female who gave a symmetrical pattern with PGK had a moderately skewed profile with M27P. Other data would support this observation (H Hinds, personal communication).
Both IP affected and normal mother/ daughter pairs (table 4) show concordance or discordance of X inactivation pattern. In the only informative case where an IP mother and her IP daughter showed extremely skewed inactivation (family 8), the chromosome carrying the IP mutation was active in both subjects. This argues against cell selection being a means of masking the IP mutation in carrier females.
We have analysed our data with respect to the family history of IP manifested by the females studied. Twenty-three cases had classical familial IP with the disease being inherited over two or more generations (fig 1) . Eight females had sporadic IP. Among the 23 cases of familial IP, nine (39%) showed symmetrical X inactivation, five (22%) were moderately skewed, and nine (39%) extremely skewed. Among the eight sporadic IP females, three (38%) showed symmetrical inactivation, three (38%) showed moderate skewing, and two (25%) showed extreme skewing. A raised frequency of extremely skewed X inactivation therefore appears to be present among both sporadic and familial IP. (It remains possible that some cases of sporadic IP may be carrying an as yet unlocalised autosomal form of the disease.)
Since we have clearly shown that selection against IP alleles does not occur invariably in lymphocytes, we were interested to find out whether this might be a more general phenomenon in tissues that directly express the IP phenotype. It is not clear which cell lineage in the skin might be involved in the blistering lesions seen early in life in IP that lead on to abnormal skin pigmentation. Skin fibroblasts and epithelial cells were examined from one subject (marked * in pedigree 1, fig 1) . A comparison was made of the X inactivation states at the HPRT locus in the lymphocyte, fibroblast, and epithelial cell DNA of this girl, and lymphocyte DNA from her mother, father, and maternal grandmother. Both mother and maternal grandmother also have IP. Blood samples from the grandmother, mother, and child all showed symmetrical patterns of X inactivation, as did skin fibroblasts and epithelial cells from the child. There appears to be no evidence in this case for a
